Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Independent association of plasma xanthine oxidoreductase activity with serum uric acid level based on stable isotope-labeled xanthine and liquid chromatography/triple quadrupole mass spectrometry: MedCity21 health examination registry.

Kurajoh M, Fukumoto S, Emoto M, Murase T, Nakamura T, Ishihara T, Go H, Yamamoto K, Nakatani S, Tsuda A, Yamada S, Morioka T, Mori K, Imanishi Y, Inaba M.

Clin Chem Lab Med. 2019 May 14. pii: /j/cclm.ahead-of-print/cclm-2019-0199/cclm-2019-0199.xml. doi: 10.1515/cclm-2019-0199. [Epub ahead of print]

PMID:
31085741
2.

Inverse association of plasma leptin with cortical thickness at distal radius determined with a quantitative ultrasound device in patients with type 2 diabetes mellitus.

Kurajoh M, Inaba M, Motoyama K, Kuriyama N, Ozaki E, Koyama T, Yamada S, Morioka T, Imanishi Y, Emoto M.

J Diabetes Investig. 2019 May 9. doi: 10.1111/jdi.13071. [Epub ahead of print]

3.

Aerobic Exercise Training with Brisk Walking Increases Intestinal Bacteroides in Healthy Elderly Women.

Morita E, Yokoyama H, Imai D, Takeda R, Ota A, Kawai E, Hisada T, Emoto M, Suzuki Y, Okazaki K.

Nutrients. 2019 Apr 17;11(4). pii: E868. doi: 10.3390/nu11040868.

4.

Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis.

Mori K, Nishide K, Okuno S, Shoji T, Emoto M, Tsuda A, Nakatani S, Imanishi Y, Ishimura E, Yamakawa T, Shoji S, Inaba M.

BMC Nephrol. 2019 Mar 28;20(1):105. doi: 10.1186/s12882-019-1271-8.

5.

Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability.

Nakatani S, Ishimura E, Machiba Y, Nakatani A, Fujimoto K, Uedono H, Okute Y, Tsuda A, Mori K, Emoto M, Inaba M.

Nephrology (Carlton). 2018 Aug;23(8):798-799. doi: 10.1111/nep.13196. No abstract available.

PMID:
30920106
6.

Attenuated Dentin Matrix Protein 1 Enhances Fibroblast Growth Factor 23 in Calvaria in a Primary Hyperparathyroidism Model.

Nagata Y, Imanishi Y, Ohara M, Maeda-Tateishi T, Miyaoka D, Hayashi N, Kurajoh M, Emoto M, Inaba M.

Endocrinology. 2019 May 1;160(5):1348-1358. doi: 10.1210/en.2019-00017.

PMID:
30916761
7.

Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients.

Toi N, Inaba M, Ishimura E, Tsugawa N, Imanishi Y, Emoto M, Hirayama Y, Nakatani S, Saito A, Yamada S.

Sci Rep. 2019 Feb 18;9(1):2207. doi: 10.1038/s41598-019-38613-8.

8.

Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk.

Hayashi M, Morioka T, Hatamori M, Kakutani Y, Yamazaki Y, Kurajoh M, Motoyama K, Mori K, Fukumoto S, Shioi A, Shoji T, Emoto M, Inaba M.

Diabetes Res Clin Pract. 2019 Feb;148:160-168. doi: 10.1016/j.diabres.2019.01.009. Epub 2019 Jan 11.

PMID:
30641171
9.

Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus.

Toi N, Inaba M, Kurajoh M, Morioka T, Hayashi N, Hirota T, Miyaoka D, Emoto M, Yamada S.

J Clin Transl Endocrinol. 2018 Dec 18;15:37-44. doi: 10.1016/j.jcte.2018.12.006. eCollection 2019 Mar.

10.

Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis.

Mori K, Emoto M, Abe M, Inaba M.

J Diabetes Sci Technol. 2019 Mar;13(2):413-414. doi: 10.1177/1932296818818429. Epub 2018 Dec 23. No abstract available.

PMID:
30580579
11.

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.

J-DAVID Investigators, Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M, Nishizawa Y.

JAMA. 2018 Dec 11;320(22):2325-2334. doi: 10.1001/jama.2018.17749.

PMID:
30535217
12.

Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients.

Nakatani S, Yasukawa K, Ishimura E, Nakatani A, Toi N, Uedono H, Tsuda A, Yamada S, Ikeda H, Mori K, Emoto M, Yatomi Y, Inaba M.

Sci Rep. 2018 Nov 14;8(1):16796. doi: 10.1038/s41598-018-35177-x.

13.

Inhibitory Effects of Intranasal Administration of Insulin on Fat Oxidation during Exercise Are Diminished in Young Overweight Individuals.

Yokoyama H, Takeda R, Kawai E, Ota A, Morita E, Imai D, Suzuki Y, Morioka T, Emoto M, Inaba M, Okazaki K.

J Clin Med. 2018 Sep 28;7(10). pii: E308. doi: 10.3390/jcm7100308.

14.

Association of Albuminuria With Intraglomerular Hydrostatic Pressure and Insulin Resistance in Subjects With Impaired Fasting Glucose and/or Impaired Glucose Tolerance.

Tsuda A, Ishimura E, Uedono H, Ochi A, Nakatani S, Morioka T, Mori K, Uchida J, Emoto M, Nakatani T, Inaba M.

Diabetes Care. 2018 Nov;41(11):2414-2420. doi: 10.2337/dc18-0718. Epub 2018 Sep 13.

PMID:
30217931
15.

Association of Decreased Handgrip Strength with Reduced Cortical Thickness in Japanese Female Patients with Type 2 Diabetes Mellitus.

Nakamura M, Inaba M, Yamada S, Ozaki E, Maruo S, Okuno S, Imanishi Y, Kuriyama N, Watanabe Y, Emoto M, Motoyama K.

Sci Rep. 2018 Jul 17;8(1):10767. doi: 10.1038/s41598-018-29061-x.

16.

Fulminant onset of insulin-dependent diabetes with positive anti-GAD antibody titers during treatment with nivolumab in a patient with NSCLC.

Matsuura N, Koh G, Konishi C, Minamino S, Takahara Y, Harada H, Kodama K, Emoto M.

Cancer Immunol Immunother. 2018 Sep;67(9):1417-1424. doi: 10.1007/s00262-018-2203-3. Epub 2018 Jul 11.

PMID:
29995236
17.

Plasma polyunsaturated fatty acid profile is associated with vascular endothelial function in patients with type 2 diabetes.

Morioka T, Emoto M, Imamura S, Kakutani Y, Yamazaki Y, Motoyama K, Mori K, Fukumoto S, Shioi A, Shoji T, Inaba M.

Diab Vasc Dis Res. 2018 Jul;15(4):352-355. doi: 10.1177/1479164118774314.

PMID:
29984618
18.

The Efficacy of Low-Density Lipoprotein Apheresis in a Patient with Drug-Resistant Minimal Change Nephrotic Syndrome: A Case Report and A Review of the Literature.

Nakatani S, Ishimura E, Okute Y, Nakatani A, Uedono H, Tsuda A, Naganuma T, Takemoto Y, Mori K, Emoto M, Inaba M.

Nephrology (Carlton). 2018 Jun;23(6):603-604. doi: 10.1111/nep.13120. Review. No abstract available.

PMID:
29890046
19.

Urinary Iron Excretion is Associated with Urinary Full-Length Megalin and Renal Oxidative Stress in Chronic Kidney Disease.

Nakatani S, Nakatani A, Ishimura E, Toi N, Tsuda A, Mori K, Emoto M, Hirayama Y, Saito A, Inaba M.

Kidney Blood Press Res. 2018;43(2):458-470. doi: 10.1159/000488470. Epub 2018 Mar 22.

20.

Correlation analysis of monocyte subsets and insulin resistance considering fetuin-A involvement in patients with type 2 diabetes.

Maruo S, Mori K, Motoyama K, Nakamura M, Kawarabayashi R, Kakutani Y, Yamazaki Y, Morioka T, Shoji T, Inaba M, Emoto M.

Clin Transl Med. 2018 Mar 27;7(1):9. doi: 10.1186/s40169-018-0187-4.

PMID:
29582352

Supplemental Content

Loading ...
Support Center